| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 2895387
[patent_doc_number] => 05183814
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-02-02
[patent_title] => 'Selective oestrogen therapy for perimenopausal or postmenopausal conditions'
[patent_app_type] => 1
[patent_app_number] => 7/362043
[patent_app_country] => US
[patent_app_date] => 1989-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5608
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/183/05183814.pdf
[firstpage_image] =>[orig_patent_app_number] => 362043
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/362043 | Selective oestrogen therapy for perimenopausal or postmenopausal conditions | Jun 5, 1989 | Issued |
| 07/361520 | METHOD FOR TREATING PERIPHERAL ATHEROSCLEROTIC DISEASE EMPLOYING AN HMG COA REDUCTASE INHIBITOR AND/OR A SQUALENE SYNTHETASE INHIBITOR | Jun 4, 1989 | Abandoned |
Array
(
[id] => 2748867
[patent_doc_number] => 05021424
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-06-04
[patent_title] => 'Vitamin composition for treatment of flea infestation in animals'
[patent_app_type] => 1
[patent_app_number] => 7/359957
[patent_app_country] => US
[patent_app_date] => 1989-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4131
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/021/05021424.pdf
[firstpage_image] =>[orig_patent_app_number] => 359957
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/359957 | Vitamin composition for treatment of flea infestation in animals | May 31, 1989 | Issued |
Array
(
[id] => 2695219
[patent_doc_number] => 04988497
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-01-29
[patent_title] => 'Process for the optical determination of lipase'
[patent_app_type] => 1
[patent_app_number] => 7/353098
[patent_app_country] => US
[patent_app_date] => 1989-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9484
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/988/04988497.pdf
[firstpage_image] =>[orig_patent_app_number] => 353098
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/353098 | Process for the optical determination of lipase | May 16, 1989 | Issued |
Array
(
[id] => 2705958
[patent_doc_number] => 05001116
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-03-19
[patent_title] => 'Inhibition of angiogenesis'
[patent_app_type] => 1
[patent_app_number] => 7/353213
[patent_app_country] => US
[patent_app_date] => 1989-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6154
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/001/05001116.pdf
[firstpage_image] =>[orig_patent_app_number] => 353213
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/353213 | Inhibition of angiogenesis | May 16, 1989 | Issued |
| 07/352253 | COMPOSITION CONTAINING DIVALENT MANGANESE ION AND METHOD FOR PREPARING THE SAME | May 15, 1989 | Abandoned |
Array
(
[id] => 2644403
[patent_doc_number] => 04895715
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-01-23
[patent_title] => 'Method of treating gynecomastia'
[patent_app_type] => 1
[patent_app_number] => 7/351261
[patent_app_country] => US
[patent_app_date] => 1989-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2586
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/895/04895715.pdf
[firstpage_image] =>[orig_patent_app_number] => 351261
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/351261 | Method of treating gynecomastia | May 8, 1989 | Issued |
Array
(
[id] => 2669682
[patent_doc_number] => 05070105
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-12-03
[patent_title] => 'Stabilized antimicrobial compositions'
[patent_app_type] => 1
[patent_app_number] => 7/346724
[patent_app_country] => US
[patent_app_date] => 1989-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7964
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/070/05070105.pdf
[firstpage_image] =>[orig_patent_app_number] => 346724
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/346724 | Stabilized antimicrobial compositions | May 2, 1989 | Issued |
| 07/346494 | METHODS FOR TREATING ANXIETY WITH SIGMA RECEPTOR LIGANDS | May 1, 1989 | Abandoned |
| 07/346340 | PERFLUOROINDANE AS A GAS TRANSPORT AGENT IN ANIMALS | Apr 27, 1989 | Abandoned |
| 07/341900 | THERAPEUTIC CHOLESTEROL GALLSTONE DISSOLUTION METHOD | Apr 23, 1989 | Abandoned |
Array
(
[id] => 2769177
[patent_doc_number] => 05075116
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-12-24
[patent_title] => 'Composition and method for treatment of macular degeneration'
[patent_app_type] => 1
[patent_app_number] => 7/341025
[patent_app_country] => US
[patent_app_date] => 1989-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4226
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/075/05075116.pdf
[firstpage_image] =>[orig_patent_app_number] => 341025
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/341025 | Composition and method for treatment of macular degeneration | Apr 19, 1989 | Issued |
Array
(
[id] => 2748707
[patent_doc_number] => 05030630
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-07-09
[patent_title] => 'Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine- for treating diseases caused by reduced secretion of growth hormone'
[patent_app_type] => 1
[patent_app_number] => 7/338690
[patent_app_country] => US
[patent_app_date] => 1989-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1519
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/030/05030630.pdf
[firstpage_image] =>[orig_patent_app_number] => 338690
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/338690 | Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine- for treating diseases caused by reduced secretion of growth hormone | Apr 16, 1989 | Issued |
| 07/337935 | SPECTRAL DIAGNOSIS OF DISEASED TISSUE | Apr 13, 1989 | Abandoned |
Array
(
[id] => 2705921
[patent_doc_number] => 05061477
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-10-29
[patent_title] => 'Use of cobalt to enhance urinary copper excretion'
[patent_app_type] => 1
[patent_app_number] => 7/336681
[patent_app_country] => US
[patent_app_date] => 1989-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 4260
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/061/05061477.pdf
[firstpage_image] =>[orig_patent_app_number] => 336681
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/336681 | Use of cobalt to enhance urinary copper excretion | Apr 10, 1989 | Issued |
| 07/334892 | SHORT-CHAIN TRIGLYCERIDES | Apr 6, 1989 | Abandoned |
Array
(
[id] => 2521643
[patent_doc_number] => 04873076
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-10-10
[patent_title] => 'Method of safely providing anesthesia or conscious sedation'
[patent_app_type] => 1
[patent_app_number] => 7/333321
[patent_app_country] => US
[patent_app_date] => 1989-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2130
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/873/04873076.pdf
[firstpage_image] =>[orig_patent_app_number] => 333321
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/333321 | Method of safely providing anesthesia or conscious sedation | Apr 5, 1989 | Issued |
Array
(
[id] => 2524552
[patent_doc_number] => 04883821
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-11-28
[patent_title] => 'Agent for treating hyperuricemia'
[patent_app_type] => 1
[patent_app_number] => 7/332011
[patent_app_country] => US
[patent_app_date] => 1989-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1847
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/883/04883821.pdf
[firstpage_image] =>[orig_patent_app_number] => 332011
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/332011 | Agent for treating hyperuricemia | Mar 30, 1989 | Issued |
Array
(
[id] => 2782241
[patent_doc_number] => 05087623
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-02-11
[patent_title] => 'Chromic picolinate treatment'
[patent_app_type] => 1
[patent_app_number] => 7/326590
[patent_app_country] => US
[patent_app_date] => 1989-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 5158
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/087/05087623.pdf
[firstpage_image] =>[orig_patent_app_number] => 326590
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/326590 | Chromic picolinate treatment | Mar 20, 1989 | Issued |
Array
(
[id] => 2790724
[patent_doc_number] => 05143732
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-09-01
[patent_title] => 'Orally administered pharmaceutical agent for iron and magnesium substitutive therapy'
[patent_app_type] => 1
[patent_app_number] => 7/323993
[patent_app_country] => US
[patent_app_date] => 1989-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1676
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/143/05143732.pdf
[firstpage_image] =>[orig_patent_app_number] => 323993
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/323993 | Orally administered pharmaceutical agent for iron and magnesium substitutive therapy | Mar 14, 1989 | Issued |